Tam Thornton
Director of Investor Relations
Replay available
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.

Director of Investor Relations
Chief Executive Officer
President of Research & Development and Technical Operations
Chief Commercial Officer
Chief Financial Officer
Chief Medical Officer
Analyst, Oppenheimer
Analyst, Barclays
Watch the replay and follow the connected company analysis, news, and investor updates for Sarepta Therapeutics, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.078 Good afternoon, and welcome to Sarepta's first quarter 2026 earnings 00:00:05.078 -- 00:00:10.586 results call. As a reminder, today's program is being recorded. 00:00:10.586 -- 00:00:15.814 I would now like to turn the call over to Tam Thornton, Sarepta's Director of Investor 00:00:15.814 -- 00:00:18.498 Relations. Please go ahead. 00:00:18.498 -- 00:00:22.363 Thank you, Antoine, and thank you all for joining today's call. 00:00:22.363 -- 00:00:27.318 Earlier this afternoon, we released our financial results for the first quarter of 2026. 00:00:27.318 -- 00:00:31.202 The press release, along with our presentation slides and supplementary information, 00:00:31.202 -- 00:00:34.806 will be available on the investor section of our company website. 00:00:34.806 -- 00:00:40.012 We plan to file our Form 10-Q for the quarter today with the SEC. 00:00:40.012 -- 00:00:44.217 Joining me on the call today are Doug Ingram, our CEO, Dr. 00:00:44.217 -- 00:00:48.802 Louise Rodino-Claypack, President of Research and Development in Technical Operations, 00:00:48.802 -- 00:00:54.249 Patrick Moss, our Chief Commercial Officer, and Ryan Wong, our chief financial officer. 00:00:54.249 -- 00:00:59.454 Additionally, joining us in the Q&A portion of the call are Ian Estepan, president 00:00:59.454 -- 00:01:05.739 and chief operations officer, and Dr. James Richardson, our chief medical officer. 00:01:05.901 -- 00:01:09.725 Before we begin the formal remarks, I would like to note that during this call, we will 00:01:09.725 -- 00:01:12.388 be making a number of forward-looking statements. 00:01:12.388 -- 00:01:17.233 Please refer to slide two of our presentation to view the formal text of these safe harbor 00:01:17.233 -- 00:01:21.630 statements. These sta...